APO Research
Talk to an analyst

APO RESEARCH · REPORT

C-C Chemokine Receptor Type 4

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global C-C Chemokine Receptor Type 4 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025189 pages

Choose your research edition.

Industry ResearchC-C Chemokine Receptor Type 4 Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal C-C Chemokine Receptor Type 4 Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal C-C Chemokine Receptor Type 4 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal C-C Chemokine Receptor Type 4 Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal C-C Chemokine Receptor Type 4 Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global C-C Chemokine Receptor Type 4 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for C-C Chemokine Receptor Type 4 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for C-C Chemokine Receptor Type 4 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for C-C Chemokine Receptor Type 4 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for C-C Chemokine Receptor Type 4 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of C-C Chemokine Receptor Type 4 include AstraZeneca Plc, Ono Pharmaceutical Co Ltd, Kyowa Hakko Kirin Co Ltd, Globavir Biosciences Inc, FLX Bio Inc, Corion Biotech Srl, ChemoCentryx Inc and Affitech A/S, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global C-C Chemokine Receptor Type 4 market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of C-C Chemokine Receptor Type 4 and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents C-C Chemokine Receptor Type 4 revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the C-C Chemokine Receptor Type 4 market size, projected growth trends, production technologies, key applications, and end-use industries.

C-C Chemokine Receptor Type 4 Segment by Company

AstraZeneca Plc

Ono Pharmaceutical Co Ltd

Kyowa Hakko Kirin Co Ltd

Globavir Biosciences Inc

FLX Bio Inc

Corion Biotech Srl

ChemoCentryx Inc

Affitech A/S

C-C Chemokine Receptor Type 4 Segment by Type

K-777

GBV-3019

E-0001163

CCX-6239

Others

C-C Chemokine Receptor Type 4 Segment by Application

Central Nervous System

Immunology

Mycosis Fungoides

Others

C-C Chemokine Receptor Type 4 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global C-C Chemokine Receptor Type 4 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of C-C Chemokine Receptor Type 4 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of C-C Chemokine Receptor Type 4.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of C-C Chemokine Receptor Type 4 in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global C-C Chemokine Receptor Type 4 industry.

Chapter 3: Detailed analysis of C-C Chemokine Receptor Type 4 companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, C-C Chemokine Receptor Type 4revenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global C-C Chemokine Receptor Type 4 Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of K-777 Table 3. Key Players of GBV-3019 Table 4. Key Players of E-0001163 Table 3. Key Players of CCX-6239 Table 4. Key Players of Others Table 5. Global C-C Chemokine Receptor Type 4 Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Central Nervous System Table 7. Key Players of Immunology Table 8. Key Players of Mycosis Fungoides Table 9. Key Players of Others Table 10. Global C-C Chemokine Receptor Type 4 Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global C-C Chemokine Receptor Type 4 Market Size by Region (2021-2026) & (US$ Million) Table 12. Global C-C Chemokine Receptor Type 4 Market Share by Region (2021-2026) Table 13. Global C-C Chemokine Receptor Type 4 Market Size by Region (2027-2032) & (US$ Million) Table 14. Global C-C Chemokine Receptor Type 4 Market Share by Region (2027-2032) Table 15. C-C Chemokine Receptor Type 4 Industry Trends Table 16. C-C Chemokine Receptor Type 4 Industry Drivers Table 17. C-C Chemokine Receptor Type 4 Industry Opportunities and Challenges Table 18. C-C Chemokine Receptor Type 4 Industry Restraints Table 19. Global C-C Chemokine Receptor Type 4 Revenue by Company (US$ Million) & (2021-2026) Table 20. Global C-C Chemokine Receptor Type 4 Revenue Market Share by Company (2021-2026) Table 21. Global C-C Chemokine Receptor Type 4 Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global C-C Chemokine Receptor Type 4 Key Company Head Office and Area Served Table 23. Global C-C Chemokine Receptor Type 4 Company, Product Type & Application Table 24. Global C-C Chemokine Receptor Type 4 Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global C-C Chemokine Receptor Type 4 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global C-C Chemokine Receptor Type 4 Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global C-C Chemokine Receptor Type 4 Market Size by Type (2021-2026) & (US$ Million) Table 29. Global C-C Chemokine Receptor Type 4 Market Size by Type (2027-2032) & (US$ Million) Table 30. Global C-C Chemokine Receptor Type 4 Revenue Market Share by Type (2021-2026) Table 31. Global C-C Chemokine Receptor Type 4 Revenue Market Share by Type (2027-2032) Table 32. Global C-C Chemokine Receptor Type 4 Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global C-C Chemokine Receptor Type 4 Market Size by Application (2021-2026) & (US$ Million) Table 34. Global C-C Chemokine Receptor Type 4 Market Size by Application (2027-2032) & (US$ Million) Table 35. Global C-C Chemokine Receptor Type 4 Revenue Market Share by Application (2021-2026) Table 36. Global C-C Chemokine Receptor Type 4 Revenue Market Share by Application (2027-2032) Table 37. AstraZeneca Plc Company Information Table 38. AstraZeneca Plc Business Overview Table 39. AstraZeneca Plc C-C Chemokine Receptor Type 4 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. AstraZeneca Plc C-C Chemokine Receptor Type 4 Product Portfolio Table 41. AstraZeneca Plc Recent Development Table 42. Ono Pharmaceutical Co Ltd Company Information Table 43. Ono Pharmaceutical Co Ltd Business Overview Table 44. Ono Pharmaceutical Co Ltd C-C Chemokine Receptor Type 4 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Ono Pharmaceutical Co Ltd C-C Chemokine Receptor Type 4 Product Portfolio Table 46. Ono Pharmaceutical Co Ltd Recent Development Table 47. Kyowa Hakko Kirin Co Ltd Company Information Table 48. Kyowa Hakko Kirin Co Ltd Business Overview Table 49. Kyowa Hakko Kirin Co Ltd C-C Chemokine Receptor Type 4 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Kyowa Hakko Kirin Co Ltd C-C Chemokine Receptor Type 4 Product Portfolio Table 51. Kyowa Hakko Kirin Co Ltd Recent Development Table 52. Globavir Biosciences Inc Company Information Table 53. Globavir Biosciences Inc Business Overview Table 54. Globavir Biosciences Inc C-C Chemokine Receptor Type 4 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Globavir Biosciences Inc C-C Chemokine Receptor Type 4 Product Portfolio Table 56. Globavir Biosciences Inc Recent Development Table 57. FLX Bio Inc Company Information Table 58. FLX Bio Inc Business Overview Table 59. FLX Bio Inc C-C Chemokine Receptor Type 4 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. FLX Bio Inc C-C Chemokine Receptor Type 4 Product Portfolio Table 61. FLX Bio Inc Recent Development Table 62. Corion Biotech Srl Company Information Table 63. Corion Biotech Srl Business Overview Table 64. Corion Biotech Srl C-C Chemokine Receptor Type 4 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Corion Biotech Srl C-C Chemokine Receptor Type 4 Product Portfolio Table 66. Corion Biotech Srl Recent Development Table 67. ChemoCentryx Inc Company Information Table 68. ChemoCentryx Inc Business Overview Table 69. ChemoCentryx Inc C-C Chemokine Receptor Type 4 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. ChemoCentryx Inc C-C Chemokine Receptor Type 4 Product Portfolio Table 71. ChemoCentryx Inc Recent Development Table 72. Affitech A/S Company Information Table 73. Affitech A/S Business Overview Table 74. Affitech A/S C-C Chemokine Receptor Type 4 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Affitech A/S C-C Chemokine Receptor Type 4 Product Portfolio Table 76. Affitech A/S Recent Development Table 77. North America C-C Chemokine Receptor Type 4 Market Size by Type (2021-2026) & (US$ Million) Table 78. North America C-C Chemokine Receptor Type 4 Market Size by Type (2027-2032) & (US$ Million) Table 79. North America C-C Chemokine Receptor Type 4 Market Size by Application (2021-2026) & (US$ Million) Table 80. North America C-C Chemokine Receptor Type 4 Market Size by Application (2027-2032) & (US$ Million) Table 81. North America C-C Chemokine Receptor Type 4 Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 82. North America C-C Chemokine Receptor Type 4 Market Size by Country (2021-2026) Table 83. North America C-C Chemokine Receptor Type 4 Market Size by Country (2027-2032) Table 84. Europe C-C Chemokine Receptor Type 4 Market Size by Type (2021-2026) & (US$ Million) Table 85. Europe C-C Chemokine Receptor Type 4 Market Size by Type (2027-2032) & (US$ Million) Table 86. Europe C-C Chemokine Receptor Type 4 Market Size by Application (2021-2026) & (US$ Million) Table 87. Europe C-C Chemokine Receptor Type 4 Market Size by Application (2027-2032) & (US$ Million) Table 88. Europe C-C Chemokine Receptor Type 4 Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. Europe C-C Chemokine Receptor Type 4 Market Size by Country (2021-2026) Table 90. Europe C-C Chemokine Receptor Type 4 Market Size by Country (2027-2032) Table 91. China C-C Chemokine Receptor Type 4 Market Size by Type (2021-2026) & (US$ Million) Table 92. China C-C Chemokine Receptor Type 4 Market Size by Type (2027-2032) & (US$ Million) Table 93. China C-C Chemokine Receptor Type 4 Market Size by Application (2021-2026) & (US$ Million) Table 94. China C-C Chemokine Receptor Type 4 Market Size by Application (2027-2032) & (US$ Million) Table 95. Asia C-C Chemokine Receptor Type 4 Market Size by Type (2021-2026) & (US$ Million) Table 96. Asia C-C Chemokine Receptor Type 4 Market Size by Type (2027-2032) & (US$ Million) Table 97. Asia C-C Chemokine Receptor Type 4 Market Size by Application (2021-2026) & (US$ Million) Table 98. Asia C-C Chemokine Receptor Type 4 Market Size by Application (2027-2032) & (US$ Million) Table 99. Asia C-C Chemokine Receptor Type 4 Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. Asia C-C Chemokine Receptor Type 4 Market Size by Country (2021-2026) Table 101. Asia C-C Chemokine Receptor Type 4 Market Size by Country (2027-2032) Table 102. South America, Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Type (2021-2026) & (US$ Million) Table 103. South America, Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Type (2027-2032) & (US$ Million) Table 104. South America, Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Application (2021-2026) & (US$ Million) Table 105. South America, Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Application (2027-2032) & (US$ Million) Table 106. South America, Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. South America, Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Country (2021-2026) Table 108. South America, Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Country (2027-2032) Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. C-C Chemokine Receptor Type 4 Product Image Figure 2. Global C-C Chemokine Receptor Type 4 Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global C-C Chemokine Receptor Type 4 Market Share by Type: 2025 VS 2032 Figure 4. K-777 Image Figure 5. GBV-3019 Image Figure 6. E-0001163 Image Figure 7. CCX-6239 Image Figure 8. Others Image Figure 9. Global C-C Chemokine Receptor Type 4 Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global C-C Chemokine Receptor Type 4 Market Share by Application: 2025 VS 2032 Figure 11. Central Nervous System Image Figure 12. Immunology Image Figure 13. Mycosis Fungoides Image Figure 14. Others Image Figure 15. Global C-C Chemokine Receptor Type 4 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global C-C Chemokine Receptor Type 4 Market Size (2021-2032) & (US$ Million) Figure 17. Global C-C Chemokine Receptor Type 4 Market Share by Region: 2025 VS 2032 Figure 18. Years Considered Figure 19. Global C-C Chemokine Receptor Type 4 Market Share by Players in 2025 Figure 20. Global Top 5 and 10 C-C Chemokine Receptor Type 4 Players Market Share by Revenue in 2025 Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global C-C Chemokine Receptor Type 4 Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global C-C Chemokine Receptor Type 4 Revenue Market Share by Type (2021-2032) Figure 24. Global C-C Chemokine Receptor Type 4 Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global C-C Chemokine Receptor Type 4 Revenue Market Share by Application (2021-2032) Figure 26. North America C-C Chemokine Receptor Type 4 Market Size (2021-2032) & (US$ Million) Figure 27. North America C-C Chemokine Receptor Type 4 Market Share by Type (2021-2032) Figure 28. North America C-C Chemokine Receptor Type 4 Market Share by Application (2021-2032) Figure 29. North America C-C Chemokine Receptor Type 4 Market Share by Country (2021-2032) Figure 30. United States C-C Chemokine Receptor Type 4 Market Size (2021-2032) & (US$ Million) Figure 31. Canada C-C Chemokine Receptor Type 4 Market Size (2021-2032) & (US$ Million) Figure 32. Mexico C-C Chemokine Receptor Type 4 Market Size (2021-2032) & (US$ Million) Figure 33. Europe C-C Chemokine Receptor Type 4 Market Size (2021-2032) & (US$ Million) Figure 34. Europe C-C Chemokine Receptor Type 4 Market Share by Type (2021-2032) Figure 35. Europe C-C Chemokine Receptor Type 4 Market Share by Application (2021-2032) Figure 36. Europe C-C Chemokine Receptor Type 4 Market Share by Country (2021-2032) Figure 37. Germany C-C Chemokine Receptor Type 4 Market Size (2021-2032) & (US$ Million) Figure 38. France C-C Chemokine Receptor Type 4 Market Size (2021-2032) & (US$ Million) Figure 39. U.K. C-C Chemokine Receptor Type 4 Market Size (2021-2032) & (US$ Million) Figure 40. Italy C-C Chemokine Receptor Type 4 Market Size (2021-2032) & (US$ Million) Figure 41. Russia C-C Chemokine Receptor Type 4 Market Size (2021-2032) & (US$ Million) Figure 42. Nordic Countries C-C Chemokine Receptor Type 4 Market Size (2021-2032) & (US$ Million) Figure 43. China C-C Chemokine Receptor Type 4 Market Size (2021-2032) & (US$ Million) Figure 44. China C-C Chemokine Receptor Type 4 Market Share by Type (2021-2032) Figure 45. China C-C Chemokine Receptor Type 4 Market Share by Application (2021-2032) Figure 46. Asia C-C Chemokine Receptor Type 4 Market Size (2021-2032) & (US$ Million) Figure 47. Asia C-C Chemokine Receptor Type 4 Market Share by Type (2021-2032) Figure 48. Asia C-C Chemokine Receptor Type 4 Market Share by Application (2021-2032) Figure 49. Asia C-C Chemokine Receptor Type 4 Market Share by Country (2021-2032) Figure 50. Japan C-C Chemokine Receptor Type 4 Market Size (2021-2032) & (US$ Million) Figure 51. South Korea C-C Chemokine Receptor Type 4 Market Size (2021-2032) & (US$ Million) Figure 52. Taiwan C-C Chemokine Receptor Type 4 Market Size (2021-2032) & (US$ Million) Figure 53. Southeast Asia C-C Chemokine Receptor Type 4 Market Size (2021-2032) & (US$ Million) Figure 54. India C-C Chemokine Receptor Type 4 Market Size (2021-2032) & (US$ Million) Figure 55. Australia C-C Chemokine Receptor Type 4 Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa C-C Chemokine Receptor Type 4 Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa C-C Chemokine Receptor Type 4 Market Share by Type (2021-2032) Figure 58. South America, Middle East & Africa C-C Chemokine Receptor Type 4 Market Share by Application (2021-2032) Figure 59. South America, Middle East & Africa C-C Chemokine Receptor Type 4 Market Share by Country (2021-2032) Figure 60. Brazil C-C Chemokine Receptor Type 4 Market Size (2021-2032) & (US$ Million) Figure 61. South Africa C-C Chemokine Receptor Type 4 Market Size (2021-2032) & (US$ Million) Figure 62. Saudi Arabia C-C Chemokine Receptor Type 4 Market Size (2021-2032) & (US$ Million) Figure 63. Turkey C-C Chemokine Receptor Type 4 Market Size (2021-2032) & (US$ Million) Figure 64. Argentina C-C Chemokine Receptor Type 4 Market Size (2021-2032) & (US$ Million) Figure 65. UAE C-C Chemokine Receptor Type 4 Market Size (2021-2032) & (US$ Million) Figure 66. Egypt C-C Chemokine Receptor Type 4 Market Size (2021-2032) & (US$ Million) Figure 67. Chile C-C Chemokine Receptor Type 4 Market Size (2021-2032) & (US$ Million) Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • K-777
  • GBV-3019
  • E-0001163
  • CCX-6239
  • Others
Applications
  • Central Nervous System
  • Immunology
  • Mycosis Fungoides
  • Others
Companies covered
  • AstraZeneca Plc
  • Ono Pharmaceutical Co Ltd
  • Kyowa Hakko Kirin Co Ltd
  • Globavir Biosciences Inc
  • FLX Bio Inc
  • Corion Biotech Srl
  • ChemoCentryx Inc
  • Affitech A/S

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global C-C Chemokine Receptor Type 4 Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 K-777
  5. 1.2.3 GBV-3019
  6. 1.2.4 E-0001163
  7. 1.2.5 CCX-6239
  8. 1.2.6 Others
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global C-C Chemokine Receptor Type 4 Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Central Nervous System
  12. 1.3.3 Immunology
  13. 1.3.4 Mycosis Fungoides
  14. 1.3.5 Others
  15. 1.4 Global Market Growth Prospects
  16. 1.5 Global C-C Chemokine Receptor Type 4 Growth Trends by Region
  17. 1.5.1 Global C-C Chemokine Receptor Type 4 Market Size by Region: 2021 VS 2025 VS 2032
  18. 1.5.2 C-C Chemokine Receptor Type 4 Market Size by Region (2021-2026)
  19. 1.5.3 C-C Chemokine Receptor Type 4 Market Size by Region (2027-2032)
  20. 1.6 Assumptions and Limitations
  21. 1.7 Study Goals and Objectives
  22. 1.8 Years Considered
2 Global C-C Chemokine Receptor Type 4 Market Dynamics
  1. 2.1 C-C Chemokine Receptor Type 4 Industry Trends
  2. 2.2 C-C Chemokine Receptor Type 4 Industry Drivers
  3. 2.3 C-C Chemokine Receptor Type 4 Industry Opportunities and Challenges
  4. 2.4 C-C Chemokine Receptor Type 4 Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global C-C Chemokine Receptor Type 4 Revenue by Company (2021-2026)
  2. 3.2 Global C-C Chemokine Receptor Type 4 Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global C-C Chemokine Receptor Type 4 Key Company Head office and Area Served
  4. 3.4 Global C-C Chemokine Receptor Type 4 Company, Product Type & Application
  5. 3.5 Global C-C Chemokine Receptor Type 4 Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global C-C Chemokine Receptor Type 4 Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 C-C Chemokine Receptor Type 4 Players Market Share by Revenue in 2025
  9. 3.6.3 2025 C-C Chemokine Receptor Type 4 Tier 1, Tier 2, and Tier 3
4 C-C Chemokine Receptor Type 4 Market by Type
  1. 4.1 Global C-C Chemokine Receptor Type 4 Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global C-C Chemokine Receptor Type 4 Market Size by Type (2021-2032)
  3. 4.3 Global C-C Chemokine Receptor Type 4 Market Size Share by Type (2021-2032)
5 C-C Chemokine Receptor Type 4 Market by Application
  1. 5.1 Global C-C Chemokine Receptor Type 4 Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global C-C Chemokine Receptor Type 4 Market Size by Application (2021-2032)
  3. 5.3 Global C-C Chemokine Receptor Type 4 Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 AstraZeneca Plc
  2. 6.1.1 AstraZeneca Plc Company Information
  3. 6.1.2 AstraZeneca Plc Business Overview
  4. 6.1.3 AstraZeneca Plc C-C Chemokine Receptor Type 4 Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 AstraZeneca Plc C-C Chemokine Receptor Type 4 Product Portfolio
  6. 6.1.5 AstraZeneca Plc Recent Developments
  7. 6.2 Ono Pharmaceutical Co Ltd
  8. 6.2.1 Ono Pharmaceutical Co Ltd Company Information
  9. 6.2.2 Ono Pharmaceutical Co Ltd Business Overview
  10. 6.2.3 Ono Pharmaceutical Co Ltd C-C Chemokine Receptor Type 4 Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Ono Pharmaceutical Co Ltd C-C Chemokine Receptor Type 4 Product Portfolio
  12. 6.2.5 Ono Pharmaceutical Co Ltd Recent Developments
  13. 6.3 Kyowa Hakko Kirin Co Ltd
  14. 6.3.1 Kyowa Hakko Kirin Co Ltd Company Information
  15. 6.3.2 Kyowa Hakko Kirin Co Ltd Business Overview
  16. 6.3.3 Kyowa Hakko Kirin Co Ltd C-C Chemokine Receptor Type 4 Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Kyowa Hakko Kirin Co Ltd C-C Chemokine Receptor Type 4 Product Portfolio
  18. 6.3.5 Kyowa Hakko Kirin Co Ltd Recent Developments
  19. 6.4 Globavir Biosciences Inc
  20. 6.4.1 Globavir Biosciences Inc Company Information
  21. 6.4.2 Globavir Biosciences Inc Business Overview
  22. 6.4.3 Globavir Biosciences Inc C-C Chemokine Receptor Type 4 Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Globavir Biosciences Inc C-C Chemokine Receptor Type 4 Product Portfolio
  24. 6.4.5 Globavir Biosciences Inc Recent Developments
  25. 6.5 FLX Bio Inc
  26. 6.5.1 FLX Bio Inc Company Information
  27. 6.5.2 FLX Bio Inc Business Overview
  28. 6.5.3 FLX Bio Inc C-C Chemokine Receptor Type 4 Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 FLX Bio Inc C-C Chemokine Receptor Type 4 Product Portfolio
  30. 6.5.5 FLX Bio Inc Recent Developments
  31. 6.6 Corion Biotech Srl
  32. 6.6.1 Corion Biotech Srl Company Information
  33. 6.6.2 Corion Biotech Srl Business Overview
  34. 6.6.3 Corion Biotech Srl C-C Chemokine Receptor Type 4 Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Corion Biotech Srl C-C Chemokine Receptor Type 4 Product Portfolio
  36. 6.6.5 Corion Biotech Srl Recent Developments
  37. 6.7 ChemoCentryx Inc
  38. 6.7.1 ChemoCentryx Inc Company Information
  39. 6.7.2 ChemoCentryx Inc Business Overview
  40. 6.7.3 ChemoCentryx Inc C-C Chemokine Receptor Type 4 Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 ChemoCentryx Inc C-C Chemokine Receptor Type 4 Product Portfolio
  42. 6.7.5 ChemoCentryx Inc Recent Developments
  43. 6.8 Affitech A/S
  44. 6.8.1 Affitech A/S Company Information
  45. 6.8.2 Affitech A/S Business Overview
  46. 6.8.3 Affitech A/S C-C Chemokine Receptor Type 4 Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Affitech A/S C-C Chemokine Receptor Type 4 Product Portfolio
  48. 6.8.5 Affitech A/S Recent Developments
7 North America
  1. 7.1 North America C-C Chemokine Receptor Type 4 Market Size (2021-2032)
  2. 7.2 North America C-C Chemokine Receptor Type 4 Market Size by Type
  3. 7.2.1 North America C-C Chemokine Receptor Type 4 Market Size by Type (2021-2026)
  4. 7.2.2 North America C-C Chemokine Receptor Type 4 Market Size by Type (2027-2032)
  5. 7.2.3 North America C-C Chemokine Receptor Type 4 Market Share by Type (2021-2032)
  6. 7.3 North America C-C Chemokine Receptor Type 4 Market Size by Application
  7. 7.3.1 North America C-C Chemokine Receptor Type 4 Market Size by Application (2021-2026)
  8. 7.3.2 North America C-C Chemokine Receptor Type 4 Market Size by Application (2027-2032)
  9. 7.3.3 North America C-C Chemokine Receptor Type 4 Market Share by Application (2021-2032)
  10. 7.4 North America C-C Chemokine Receptor Type 4 Market Size by Country
  11. 7.4.1 North America C-C Chemokine Receptor Type 4 Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America C-C Chemokine Receptor Type 4 Market Size by Country (2021-2026)
  13. 7.4.3 North America C-C Chemokine Receptor Type 4 Market Size by Country (2027-2032)
  14. 7.4.4 North America C-C Chemokine Receptor Type 4 Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe C-C Chemokine Receptor Type 4 Market Size (2021-2032)
  2. 8.2 Europe C-C Chemokine Receptor Type 4 Market Size by Type
  3. 8.2.1 Europe C-C Chemokine Receptor Type 4 Market Size by Type (2021-2026)
  4. 8.2.2 Europe C-C Chemokine Receptor Type 4 Market Size by Type (2027-2032)
  5. 8.2.3 Europe C-C Chemokine Receptor Type 4 Market Share by Type (2021-2032)
  6. 8.3 Europe C-C Chemokine Receptor Type 4 Market Size by Application
  7. 8.3.1 Europe C-C Chemokine Receptor Type 4 Market Size by Application (2021-2026)
  8. 8.3.2 Europe C-C Chemokine Receptor Type 4 Market Size by Application (2027-2032)
  9. 8.3.3 Europe C-C Chemokine Receptor Type 4 Market Share by Application (2021-2032)
  10. 8.4 Europe C-C Chemokine Receptor Type 4 Market Size by Country
  11. 8.4.1 Europe C-C Chemokine Receptor Type 4 Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe C-C Chemokine Receptor Type 4 Market Size by Country (2021-2026)
  13. 8.4.3 Europe C-C Chemokine Receptor Type 4 Market Size by Country (2027-2032)
  14. 8.4.4 Europe C-C Chemokine Receptor Type 4 Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China C-C Chemokine Receptor Type 4 Market Size (2021-2032)
  2. 9.2 China C-C Chemokine Receptor Type 4 Market Size by Type
  3. 9.2.1 China C-C Chemokine Receptor Type 4 Market Size by Type (2021-2026)
  4. 9.2.2 China C-C Chemokine Receptor Type 4 Market Size by Type (2027-2032)
  5. 9.2.3 China C-C Chemokine Receptor Type 4 Market Share by Type (2021-2032)
  6. 9.3 China C-C Chemokine Receptor Type 4 Market Size by Application
  7. 9.3.1 China C-C Chemokine Receptor Type 4 Market Size by Application (2021-2026)
  8. 9.3.2 China C-C Chemokine Receptor Type 4 Market Size by Application (2027-2032)
  9. 9.3.3 China C-C Chemokine Receptor Type 4 Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia C-C Chemokine Receptor Type 4 Market Size (2021-2032)
  2. 10.2 Asia C-C Chemokine Receptor Type 4 Market Size by Type
  3. 10.2.1 Asia C-C Chemokine Receptor Type 4 Market Size by Type (2021-2026)
  4. 10.2.2 Asia C-C Chemokine Receptor Type 4 Market Size by Type (2027-2032)
  5. 10.2.3 Asia C-C Chemokine Receptor Type 4 Market Share by Type (2021-2032)
  6. 10.3 Asia C-C Chemokine Receptor Type 4 Market Size by Application
  7. 10.3.1 Asia C-C Chemokine Receptor Type 4 Market Size by Application (2021-2026)
  8. 10.3.2 Asia C-C Chemokine Receptor Type 4 Market Size by Application (2027-2032)
  9. 10.3.3 Asia C-C Chemokine Receptor Type 4 Market Share by Application (2021-2032)
  10. 10.4 Asia C-C Chemokine Receptor Type 4 Market Size by Country
  11. 10.4.1 Asia C-C Chemokine Receptor Type 4 Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia C-C Chemokine Receptor Type 4 Market Size by Country (2021-2026)
  13. 10.4.3 Asia C-C Chemokine Receptor Type 4 Market Size by Country (2027-2032)
  14. 10.4.4 Asia C-C Chemokine Receptor Type 4 Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa C-C Chemokine Receptor Type 4 Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Type
  3. 11.2.1 South America, Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa C-C Chemokine Receptor Type 4 Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Application
  7. 11.3.1 South America, Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa C-C Chemokine Receptor Type 4 Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Country
  11. 11.4.1 South America, Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa C-C Chemokine Receptor Type 4 Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst